High Point Bank & Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$14K Hold
193
﹤0.01% 321
2016
Q3
$15K Hold
193
﹤0.01% 322
2016
Q2
$16K Hold
193
﹤0.01% 305
2016
Q1
$18K Hold
193
﹤0.01% 305
2015
Q4
$20K Hold
193
0.01% 293
2015
Q3
$19K Hold
193
0.01% 310
2015
Q2
$23K Hold
193
0.01% 292
2015
Q1
$19K Hold
193
0.01% 316
2014
Q4
$18K Hold
193
0.01% 326
2014
Q3
$21K Hold
193
0.01% 307
2014
Q2
$16K Hold
193
0.01% 322
2014
Q1
$14K Hold
193
﹤0.01% 324
2013
Q4
$14K Hold
193
﹤0.01% 324
2013
Q3
$12K Hold
193
﹤0.01% 337
2013
Q2
$10K Buy
+193
New +$10.1K ﹤0.01% 345

Other funds holding GILD

High Point Bank & Trust's GILD Position: Q4 2016 in Review

High Point Bank & Trust held its Gilead Sciences (GILD) position steady in Q4 2016 at 193 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #321.

High Point Bank & Trust first reported a position in GILD in Q2 2013 and has held it in 15 quarters since. The position peaked at $23K in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • High Point Bank & Trust held 193 shares of Gilead Sciences worth $14K as of Q4 2016.
  • High Point Bank & Trust left its Gilead Sciences share count unchanged in Q4 2016.
  • Gilead Sciences made up ﹤0.01% of High Point Bank & Trust's portfolio in Q4 2016, its #321 holding.
  • High Point Bank & Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 15 quarters since.
  • High Point Bank & Trust's Gilead Sciences position peaked at $23K in Q2 2015.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.